Increasing numbers of studies have identified HMGB1 as an activity biomarker in various autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus and vitiligo (6, 7). The gene discussed is HMGB1; the disease is autoimmune disease.